Publication:
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders

dc.contributor.authorRuíz Ruíz, Juan J.
dc.contributor.authorMartinez Delgado, José M.
dc.contributor.authorGarcía-Marchena, Nuria
dc.contributor.authoraffiliation[Ruíz Ruíz,JJ] Centro Provincial de Drogodependencias, Málaga, Spain. [Martinez Delgado,JM] Centro Provincial de Drogodependencias, Cádiz, Spain. [García-Marchena,N] Unidad de Adicciones Servicio de Medicina Interna, Institut D’Investigació en Ciènces de La Salut Germans Trias I Pujol (IGTP), Campus Can Ruti, Badalona, Barcelona, Spain. [García-Marchena,N] Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.
dc.date.accessioned2024-02-19T15:26:51Z
dc.date.available2024-02-19T15:26:51Z
dc.date.issued2021-04-13
dc.description.abstractBackground: Methadone and buprenorphine are the most prevalent types of opioid maintenance programs in Andalusia. The main objective is comparing the functional status of patients with pharmacological opioid maintenance treatments according to diferent socio-demographic characteristic, health and disabilities domains and sexual difculties. Methods: A total of 593 patients from the Andalusia community, 329 were undergoing methadone treatment and 264 were undergoing buprenorphine treatment. The patients were interviewed by socio-demographic and opioid related variables, assessed by functioning, disability and health domains (WHODAS 2.0.) and for sexual problems (PRSexDQ-SALSEX). Results: We found signifcant diferences in the socio-demographic and the opioid-related variables as the onset of opioid use, being on previous maintenance programs, opioid intravenous use, the length of previous maintenance programs, polydrug use and elevated seroprevalence rates (HCV and HIV) between the methadone group and the buprenorphine group. Regarding health and disability domains there were diferences in the Understanding and communication domain, Getting around domain, Participation in society domain and in the WHODAS 2.0. simple and complex score, favoring buprenorphine-treated patients. The methadone group referred elevated sexual impairments compared with the buprenorphine group. Opioid-related variables as seroprevalence rates, other previous lifetime maintenance program, the daily opioid dosage and the daily alcohol use are the most discriminative variables between both groups. Participation in society variables and sexual problems were the most important clinical variables in distinguishing the methadone group from the buprenorphine group regarding their functional status. Conclusions: The methadone group showed higher prevalence in opioid dependence-related variables, elevated disabilities in participation in society activities and sexual problems compared with the buprenorphine group. This study shows the importance of carry out a functional evaluation in the healthcare follow-up, especially in those areas related with social activity and with sexual problems.
dc.description.sponsorshipThis work has been funded by Sociedad Médica Andaluza de Adicciones y Patologías Médicas Asociadas (SOMAPA) and supported by Research Project funded by Consejería de Salud y Bienestar Social, Junta de Andalucía Fundación Progreso y Salud (PI-0140-2018). NGM holds a Sara Borrell research contract (CD19/00019) funded by Instituto de Salud Carlos III (ISC-III) and European Regional Development Funds-European Union (ERDF-EU).
dc.identifier.doi10.1186/s12954-021-00488-2
dc.identifier.e-issn1477-7517es_ES
dc.identifier.journalHarm Reduction Journales_ES
dc.identifier.otherhttp://hdl.handle.net/10668/4543
dc.identifier.pubmedID33849574es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18309
dc.language.isoeng
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00488-2es
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectOpioid use disorders
dc.subjectMethadone
dc.subjectBuprenorphine
dc.subjectFunctional status
dc.subjectSexual dysfunction
dc.subjectTrastornos relacionados con opiáceos
dc.subjectMetadona
dc.subjectBuprenorfina
dc.subjectEstado funcional
dc.subjectDisfunciones sexuales fisiológicas
dc.subject.meshHumans
dc.subject.meshMethadone
dc.subject.meshOpiate Substitution Treatment
dc.subject.meshSeroepidemiologic Studies
dc.subject.meshBuprenorphine
dc.subject.meshOpioid-Related Disorders
dc.subject.meshSexual Dysfunction, Physiological
dc.subject.meshSocial Behavior Disorders
dc.titleEvaluation of functional status among patients undergoing maintenance treatments for opioid use disorders
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files